Clinical utility of systemic venous sampling of FGF23 for identifying tumours responsible for tumour-induced osteomalacia

Authors


Dr. Seiji Fukumoto, Division of Nephrology & Endocrinology, Department of Medicine, University of Tokyo Hospital, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655 Japan.
(fax: +81 3 5800 9836; e-mail: fukumoto-tky@umin.ac.jp).

Ancillary